McKesson to pay $150M in prescription drug probe

Drug distributor McKesson will pay a record $150 million civil penalty for alleged violations of the Controlled Substances Act, the Justice Department announced today. The settlement also imposes new and enhanced compliance obligations, as well as an independent monitor—the first independent monitor of its kind in a CSA civil penalty ...

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.